HIV-1: Nature's master of disguise

Nature Medicine

Volumn 9, Issue 4, 2003, Pages 393-394

  Mascola, John R ^a   Montefiori, David C ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE DERIVATIVE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS IMMUNITY; VIRUS MUTATION;

AIDS VACCINES; ANTIBODIES, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; MUTATION; NEUTRALIZATION TESTS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037393393     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0403-393     Document Type: Short Survey

References (12)

1. Letvin, N.L., Barouch, D.H. & Montefiori, D.C. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu. Rev. Immunol. 20, 73-99 (2002).
2. Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307-312 (2003).
3. Wyatt, R. & Sodroski, J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884-1888 (1998).
4. Albert, J. et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4, 107-112 (1990).
5. Narayan, O., Griffin, D.E. & Chase, J. Antigenic shift of visna virus in persistently infected sheep. Science 197, 376-378 (1977).
6. Howe, L., Leroux, C., Issel, C.J. & Montelaro, R.C. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J. Virol. 76, 10588-10597 (2002).
7. Burns, D.P., Collignon, C. & Desrosiers, R.C. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J. Virol. 67, 4104-4113 (1993).
8. Kwong, P.D. et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678-682 (2002).
9. Kolchinsky, P., Kiprilov, E. & Sodroski, J. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. J. Virol. 75, 2041-2050 (2001).
10. Montefiori, D.C. et al. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1 infected individual. J. Immunol. (in the press).
11. Richman, D.D., Wrin, T.L., Little, S.J. & Petropoulos, C.J. Rapid evolution of the neutralizing antibody response to HIV-1 infection. Proc. Natl. Acad. Sci. USA (in the press).
12. Wrin, T. et al. Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J. Acquir. Immune. Defic. Syndr. 7, 211-219 (1994).